RUA Life Sciences (LON:RUA) Hits New 1-Year High – Still a Buy?

RUA Life Sciences plc (LON:RUA)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 18.50 and last traded at GBX 18.45, with a volume of 1487846 shares trading hands. The stock had previously closed at GBX 17.

RUA Life Sciences Stock Down 0.7%

The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The firm has a fifty day simple moving average of GBX 13.72 and a 200-day simple moving average of GBX 12.99. The company has a market capitalization of £11.09 million, a PE ratio of -2.61 and a beta of 0.63.

RUA Life Sciences (LON:RUA) last posted its quarterly earnings data on Friday, January 30th. The company reported GBX (0.23) earnings per share (EPS) for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.